New FDA Fast-Track System Is Getting Drugs to Patients Years Earlier
The FDA's expedited drug approval system is genuinely getting treatments to patients years earlier than the traditional pathway allows.
Category Uncategorized
The Drug That Was Banned Then Brought Back — And Why Doctors Are Cautious
The drug most often at the center of this "banned then brought back" conversation in dementia care is aducanumab, marketed as Aduhelm by Biogen.
What Biosimilars Mean for Patients Who Take Expensive Biologics
Biosimilars are poised to save patients who depend on expensive biologic drugs thousands of dollars a year, and in some cases, they already are.
New Drug for Postpartum Depression Works Faster Than Anything Before
A new drug called luvesilocin may soon change the timeline for treating postpartum depression from weeks down to a single day.
Why Doctors Prescribe Medications for Conditions They Weren’t Designed For
Doctors prescribe medications for conditions they weren't originally designed for because, in many cases, no approved alternative exists, or every...
The Drug That’s Saving Opioid Overdose Victims — Now Available Without Prescription
Naloxone — sold under the brand name Narcan — is now available over the counter at pharmacies, grocery stores, and even gas stations across the United...
New Bipolar Drug Has Fewer Side Effects Than Any That Came Before
Among the newer generation of bipolar medications, CAPLYTA (lumateperone) stands out as the drug with the most favorable side effect profile documented in...
The Antidepressant That Works in 2 Hours — Not 6 Weeks
The antidepressant that works in two hours is ketamine, and its FDA-approved nasal spray derivative, esketamine (brand name Spravato).
Vilazodone for Depression: The Newer SSRI Doctors Are Turning To
Vilazodone, sold under the brand name Viibryd, is a newer antidepressant that works differently from the SSRIs most people know.
The Anxiety Drug That’s Replacing Benzodiazepines in Some Practices
Buspirone, a decades-old medication that works on serotonin receptors rather than the GABA system targeted by benzodiazepines, has become the leading...